Nanobiotix S.A.NBTX
ASignal's systematic analysis rates NBTX as Bearish.
Reflects the latest available analysis · analyzed Aug 20, 2026
The case on NBTX
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- MACD above signal line with expanding histogram indicating strengthening momentum
- Price trading above 20-day and 50-day moving averages
- RSI in neutral range (57.1), not overbought
- Gross margin at 100% indicating strong pricing or cost control
- Negative forward P/E (-127.97x) indicating unprofitability
- Negative price-to-book ratio (-21.49x) suggesting accounting issues or negative equity
- Operating margin at -196.42%, indicating severe operating losses
- Negative free cash flow (-$7.89M) and operating cash flow (-$33.42M)
- EV/EBITDA at -213.45x, reflecting deep unprofitability
- No Reddit mentions, indicating low retail investor interest or visibility
See the full verdict on NBTX
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes NBTX
Most investors never get a second opinion, let alone several. ASignal runs NBTX past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.